טוען...
Biosimilars and the extrapolation of indications for inflammatory conditions
Extrapolation is the approval of a biosimilar for use in an indication held by the originator biologic not directly studied in a comparative clinical trial with the biosimilar. Extrapolation is a scientific rationale that bridges all the data collected (ie, totality of the evidence) from one indicat...
שמור ב:
| הוצא לאור ב: | Biologics |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5322938/ https://ncbi.nlm.nih.gov/pubmed/28255229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S124476 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|